Side-by-side comparison of AI visibility scores, market position, and capabilities
Spend analytics and procurement intelligence platform; Dubai and London; raised $15M+; AI-powered spend classification and tail spend automation for global enterprises.
Simfoni is a spend analytics and procurement intelligence platform with offices in Dubai and London that provides global enterprises with AI-powered spend classification, category analytics, and tail spend automation capabilities. The company raised over $15 million in funding and serves procurement teams across the Middle East, Europe, and North America.\n\nThe platform's spend analytics engine ingests raw financial and procurement data from ERP systems, cleansing and classifying it into standardized category taxonomies with AI assistance. This process transforms fragmented, inconsistent spend data into actionable intelligence that procurement leaders can use to identify savings opportunities, monitor supplier concentration risks, and track category performance over time.\n\nSimfoni also includes an integrated tail spend marketplace that allows procurement teams to source and purchase low-value items from pre-approved supplier catalogs, combining the intelligence layer with an execution capability in a single platform. Its Middle Eastern heritage and dual-geography presence in Dubai and London have made it a preferred choice for organizations with significant procurement operations across the Gulf region and EMEA.
a2z Radiology AI raised $20M in 2025 for its whole-body AI that simultaneously screens for 24+ conditions across CT scans — from incidental cancers to cardiovascular risk — in a single automated read.
a2z Radiology AI has developed a whole-body CT analysis platform that simultaneously screens for over 24 medical conditions across a single CT scan, including incidental cancers, coronary artery disease, aortic aneurysm, bone density loss, and organ abnormalities. The AI acts as a second reader that radiologists can use to catch incidental findings that fall outside the primary reason for a scan — a major source of missed diagnoses.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.